157 related articles for article (PubMed ID: 37870510)
1. A Nonhormonal Selective NK3R Antagonist for Moderate to Severe Vasomotor Symptoms in Menopause.
O'Malley PA
Clin Nurse Spec; 2023 Nov-Dec 01; 37(6):259-261. PubMed ID: 37870510
[No Abstract] [Full Text] [Related]
2. A Nonhormonal Treatment for Moderate to Severe Vasomotor Symptoms of Menopause.
Fantasia HC
Nurs Womens Health; 2016; 20(5):511-518. PubMed ID: 27719781
[TBL] [Abstract][Full Text] [Related]
3. A Novel Nonhormonal Treatment for Vasomotor Symptoms of Menopause.
Javernick JA
Nurs Womens Health; 2024 Feb; 28(1):80-84. PubMed ID: 38161058
[TBL] [Abstract][Full Text] [Related]
4. Neurokinin 3 Receptor Antagonism Reveals Roles for Neurokinin B in the Regulation of Gonadotropin Secretion and Hot Flashes in Postmenopausal Women.
Skorupskaite K; George JT; Veldhuis JD; Millar RP; Anderson RA
Neuroendocrinology; 2018; 106(2):148-157. PubMed ID: 28380486
[TBL] [Abstract][Full Text] [Related]
5. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
[TBL] [Abstract][Full Text] [Related]
6. Fezolinetant: First Approval.
Lee A
Drugs; 2023 Aug; 83(12):1137-1141. PubMed ID: 37462862
[TBL] [Abstract][Full Text] [Related]
7. Fezolinetant in the treatment of vasomotor symptoms associated with menopause.
Depypere H; Lademacher C; Siddiqui E; Fraser GL
Expert Opin Investig Drugs; 2021 Jul; 30(7):681-694. PubMed ID: 33724119
[No Abstract] [Full Text] [Related]
8. Menopause.
Carter AE; Merriam S
Med Clin North Am; 2023 Mar; 107(2):199-212. PubMed ID: 36759091
[TBL] [Abstract][Full Text] [Related]
9. An overview of menopause associated vasomotor symptoms and options available in its management.
Okeke TC; Ezenyeaku CC; Ikeako LC; Agu PU
Niger J Med; 2013; 22(1):7-14. PubMed ID: 23441513
[TBL] [Abstract][Full Text] [Related]
10. Stellate ganglion block as a treatment for vasomotor symptoms: Clinical application.
Lee YS; Wie C; Pew S; Kling JM
Cleve Clin J Med; 2022 Mar; 89(3):147-153. PubMed ID: 35232827
[TBL] [Abstract][Full Text] [Related]
11. NAMS releases position statement on the treatment of vasomotor symptoms associated with menopause.
Neff MJ
Am Fam Physician; 2004 Jul; 70(2):393-4, 396, 399. PubMed ID: 15291096
[TBL] [Abstract][Full Text] [Related]
12. New generation nonhormonal management for hot flashes.
Imai A; Matsunami K; Takagi H; Ichigo S
Gynecol Endocrinol; 2013 Jan; 29(1):63-6. PubMed ID: 22809093
[TBL] [Abstract][Full Text] [Related]
13. Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms.
Umland EM
J Manag Care Pharm; 2008 Apr; 14(3 Suppl):14-9. PubMed ID: 18439062
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Menopausal Vasomotor Symptoms With Fezolinetant, a Neurokinin 3 Receptor Antagonist: A Phase 2a Trial.
Depypere H; Timmerman D; Donders G; Sieprath P; Ramael S; Combalbert J; Hoveyda HR; Fraser GL
J Clin Endocrinol Metab; 2019 Dec; 104(12):5893-5905. PubMed ID: 31415087
[TBL] [Abstract][Full Text] [Related]
15. Nonhormonal alternatives to treating menopausal symptoms.
Cass I; Runowicz CD
Am J Manag Care; 1998 May; 4(5):732-8; quiz 739-40. PubMed ID: 10179926
[No Abstract] [Full Text] [Related]
16. Management of Menopause Symptoms and Quality of Life during the Menopause Transition.
Ye L; Knox B; Hickey M
Endocrinol Metab Clin North Am; 2022 Dec; 51(4):817-836. PubMed ID: 36244695
[TBL] [Abstract][Full Text] [Related]
17. Costs of hormonal and nonhormonal prescription medications for hot flashes.
Williams-Frame A; Carpenter JS
Womens Health (Lond); 2009 Sep; 5(5):497-502. PubMed ID: 19702449
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, severity, and associated factors in women in East Asia with moderate-to-severe vasomotor symptoms associated with menopause.
Yu Q; Chae HD; Hsiao SM; Xie J; Blogg M; Sumarsono B; Kim S
Menopause; 2022 May; 29(5):553-563. PubMed ID: 35231007
[TBL] [Abstract][Full Text] [Related]
19. Neurokinin 3 Receptor Antagonism: A Novel Treatment for Menopausal Hot Flushes.
Modi M; Dhillo WS
Neuroendocrinology; 2019; 109(3):242-248. PubMed ID: 30504731
[TBL] [Abstract][Full Text] [Related]
20. Menopause review: Emerging treatments for menopausal symptoms.
Patel B; S Dhillo W
Best Pract Res Clin Obstet Gynaecol; 2022 May; 81():134-144. PubMed ID: 34965909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
